The Use of Antidepressants in Patients with Heart Failure
| Autor: | Rakan Faraj, Ahmed Alghanim, Rahaf Ali Alqahtani, Faisal E. Almutairi, Shmylan Alharbi, Hind Almodaimegh, Norah A. Alsumih, Turki Alsubeai |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Quality of life
medicine.medical_specialty Population Heart failure 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Rating scale Internal medicine medicine Medical history 030212 general & internal medicine education Depression (differential diagnoses) education.field_of_study business.industry Depression Selective serotonin uptake inhibitors Antidepressants medicine.disease New York Heart Association Functional Classification Antidepressant Original Article Cardiology and Cardiovascular Medicine business |
| Zdroj: | Journal of the Saudi Heart Association |
| ISSN: | 2212-5043 1016-7315 |
| Popis: | Background Heart failure (HF) is a chronic disease affecting patients’ quality of life (QoL) and may cause depression. Recent studies reported that the prevalence of depression in patients with HF is 21.5%. Antidepressants, mainly selective serotonin reuptake inhibitors, are usually prescribed for HF patients diagnosed with depression. Some evidence supports antidepressant’s role in improving symptoms by enhancing the psychological aspect of their QoL. Depression screening and treatment are important in the multidisciplinary management; however, their survival benefits are inconsistent. In our study, we aim to investigate the prevalence of depression and the use of antidepressants in patients with HF as well as to determine the acceptance of using antidepressants in such patients. Methods This is a cross-sectional study conducted by interviewing HF outpatients at National Guard Hospital in Riyadh. Patients were assessed using Hamilton depression rating scale. Results A total of 306 patients were included, with the majority (69%) being male and aged >61 years (60%). Patients’ medical history was classified into different groups, with the largest proportion (39.9%) in the diabetic-hypertensive group, followed by a diabetic group (21.2%) and a hypertensive group (10.8%). Patients were classified according to the New York Heart Association Functional Classification, and most patients were in Class I (61.8%). Some of the patients (8.5%) had been diagnosed with depression. There was no statistically significant association between HF and depression (p > 0.05). However, 5.6% of patients had been prescribed antidepressants and 17.1% of patients believed that they required antidepressants. Moreover, there was a statically significant association between medical history and development of depression (p = 0.014). Conclusions The prevalence of depression in HF patients in our population was lower than reported. There was no association between HF stage, depression, and antidepressant use. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|